BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for GH Research PLC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-14 09:54 am Purchase |
2023-12-31 | 13G | GH Research PLC GHRS |
BIOTECHNOLOGY VALUE FUND L P | 10,400,158 19.990% |
1,125,000![]() (+12.13%) |
Filing |
2022-02-14 12:53 pm Purchase |
2021-12-31 | 13G | GH Research PLC GHRS |
BIOTECHNOLOGY VALUE FUND L P | 9,275,158 17.800% |
9,275,158![]() (New Position) |
Filing |